Mobile Menu

Search Results

Search results for: Drug Response

The Genetics Of Alzheimer’s: Uncovering new Mechanisms and Drug Targets

An understanding of the environmental and genetic risk of Alzheimer’s Disease is vital for the production of more effective therapies. […]

New class of precision oncology drug strips cancer of its DNA defences

Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]

FDA releases list of evidence-based pharmacogenetic variants

Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.

Genomics: Not all doom and gloom

In the past Genomics has faced a lot of controversy, particularly in relation to eugenics. Even today, applications of genomics, […]

The benefits of using genomics in clinical trials

Genomics has the potential to improve efficacy of drugs and accelerate precision healthcare, but one area with the biggest potential […]

Continuomics and the future of clinical trials

“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]

FoG Presentation 2020 Dennis Wang, University of Sheffield: Looking beyond the hype: Applied AI and machine learning in translational medicine

Dennis graduated from the University of British Columbia (Vancouver, Canada) with a BSc in Computer Science, Microbiology and Immunology. He […]

Interview with Dr Cecilia Domínquez Conde, Postdoctoral Fellow, Teichmann Lab, Wellcome Sanger Institute

Dr Cecilia Dominguez Conde is a postdoctoral fellow at the Teichmann Lab, Wellcome Sanger Institute. During her PhD, she discovered […]

Genetically engineered probiotics

Advancements in the field of synthetic biology, genetic engineering and genome sequencing technologies have provided the opportunity to improve the […]

Barriers and facilitators to implementing pharmacogenomic screening

We summarise a recent pilot study, published as preprint in medRxiv, that explored the practical barriers and facilitators experienced by […]